Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
about
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming.ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
P2860
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@en
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@nl
type
label
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@en
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@nl
prefLabel
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@en
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@nl
P2093
P2860
P356
P1476
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance.
@en
P2093
Agostina Nardone
Andrew Dodson
Cloud Paweletz
Clyde Bango
Gilles Buchwalter
Henry W Long
Hisham Mohammed
MacIntosh Cornwell
Mai Nguyen
P2860
P304
E4482-E4491
P356
10.1073/PNAS.1620993114
P407
P577
2017-05-15T00:00:00Z